Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Council Bluffs, Iowa Clinical Trials

A listing of Council Bluffs, Iowa clinical trials actively recruiting patient volunteers.

RESULTS

Found (5) clinical trials

PTI-125 100 mg for Mild-to-moderate Alzheimer's Disease Patients

The objectives of this study are to establish 1-year safety and to investigate the effect of PTI-125 on biomarkers, cognition and neuropsychiatric symptoms during 12-month repeat-dose oral administration in mild-to-moderate AD patients, 50-85 years of age.

Phase

5.33 miles

Learn More »

Luminopia One Amblyopia Vision Improvement Study

The proposed study is a multi-center randomized controlled clinical trial which compares the mean change in amblyopic eye Best Corrected Visual Acuity from baseline with Luminopia One ("therapeutic") to refractive correction ("control"). One-hundred and forty participants (n = 140) aged 4-7 years will be enrolled. Participants will be randomized 1:1 …

Phase N/A

5.66 miles

Learn More »

PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on Apixaban

There is an unmet clinical need for an alternative to warfarin, such as a direct oral anticoagulant (DOAC), as anticoagulation in participants with an aortic mechanical prosthetic valve. Some participants may be genetically hyper- or hypo-responsive to warfarin, which makes management difficult. Another small group of participants is allergic to …

Phase

5.66 miles

Learn More »

Pembrolizumab and Dasatinib Imatinib Mesylate or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease

PRIMARY OBJECTIVES: I. Assess the proportion of chronic myelogenous leukemia (CML) patients on stable-dose tyrosine kinase inhibitor (TKI) who convert to undetectable minimal residual disease (UMRD) (molecular response [MR]^4.5) during or within 2 years of initiating pembrolizumab therapy. SECONDARY OBJECTIVES: I. Among patients who have converted to UMRD (MR^4.5), assess …

Phase

5.66 miles

Learn More »

Adaptive COVID-19 Treatment Trial 2 (ACTT-II)

This study is an adaptive randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of novel therapeutic agents in hospitalized adults diagnosed with COVID-19. The study is a multicenter trial that will be conducted in up to approximately 100 sites globally. The study will compare different investigational therapeutic agents …

Phase

5.66 miles

Learn More »